Lapatinib base
CAS:231277-92-2
Specification: Assay 99%
Molecular Formula:C29H26ClFN4O4S
Molecular Weight:581.0575432g/mol
Description:lapatinib could be used as a first-line therapy regimen combined with anti-hormonal therapy for patients with hormone-sensitive, metastatic (or advanced) breast cancer in Europe and the United States.
For more information OR other specifications of the products, please contact us.
Send Enquiry Online
For more information OR other products. Please contact us by Email, Tel or Send online enquiry. We will reply you as soon as possible.
1. E-mail: se(at)serebiomedical.com
2. Tel: +1 571 572 9408
3. WhatsApp: +1 571 572 9408